论文部分内容阅读
目的观察MPT方案与VAD方案治疗老年多发性骨髓瘤的效果。方法选取多发性骨髓瘤患者46例作为研究对象,随机分为A组与B组,每组23例。A组采用MPT方案治疗,B组采用VAD方案治疗,观察2组患者临床治疗效果及不良反应。结果 A组临床治疗总有效率为74.0%,高于B组的70.0%,但差异无统计学意义(P>0.05)。不良反应方面,A组外周神经病变、嗜睡患者发生率高于B组,B组3级血液学毒性发生率高于A组,2组患者不良反应均可耐受。结论 MPT方案与VAD方案均为国内治疗老年多发性骨髓瘤经济、有效、较为安全方案,值得临床推广使用。
Objective To observe the effect of MPT and VAD in the treatment of multiple myeloma in the elderly. Methods Forty-six patients with multiple myeloma were randomly divided into group A and group B, with 23 cases in each group. A group treated with MPT program, B group treated with VAD program, observed two groups of patients with clinical treatment and adverse reactions. Results The total effective rate of clinical treatment in group A was 74.0%, which was higher than 70.0% in group B, but the difference was not statistically significant (P> 0.05). Adverse reactions, the incidence of peripheral neuropathy, drowsiness in group A was higher than that in group B, and the grade 3 hematologic toxicity in group B was higher than that in group A, and the adverse reactions in both groups were tolerable. Conclusions The MPT and VAD regimens are all economical, effective and safe in the treatment of multiple myeloma in the elderly in China. They are worthy of clinical application.